For in vitro diagnostic use. Others Elecsys HBeAg IVD Elecsys® HBeAg CPS_000477 11820583122 HBeAg Elecsys cobas e 100 Elecsys HBeAg 04015630911677 Reagents, kits 100 tests cobas e 411/601/602 true 07027427190 HBeAg Elecsys E2G 300 Elecsys HBeAg 04015630939862 Reagents, kits 300 tests cobas e 402/801 true 11820583160 HBeAg Elecsys cobas e 100 Elecsys HBeAg 07613336154281 Reagents, kits 100 tests cobas e 411/601/602 true 11820583500 Elecsys HBeAg en 20 FF000000047B7D0E FF0000000028EA0E 11820583122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027427500 Elecsys HBeAg en 2 FF000000047B850E FF00000001A9760E 07027427190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07027427501 Elecsys HBeAg en 2 FF0000000620190E FF000000061F510E 07027427190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum or plasma (K2‑EDTA, lithium or sodium heparin, and sodium citrate) in adult patients with symptoms of hepatitis or at risk for hepatitis B virus (HBV) infection. The assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals with acute or chronic hepatitis B or recovery from hepatitis B infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 07027427500 Elecsys HBeAg en 3 FF00000004B0E10E FF00000000E86E0E 07027427190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en ms_11820583160_USA Elecsys HBeAg en 3 FF00000001BDC60E FF00000000CF7B0E 11820583160 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum or plasma (K2‑EDTA, lithium or sodium heparin, and sodium citrate) in adult patients with symptoms of hepatitis or at risk for hepatitis B virus (HBV) infection. The assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals with acute or chronic hepatitis B or recovery from hepatitis B infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the MODULAR ANALYTICS E170 and cobas e 602 immunoassay analyzers. en 11820583501 Elecsys HBeAg en 4 FF000000052D990E FF00000001BDC60E 11820583160 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of hepatitis B e antigen (HBeAg) in human serum or plasma (K2‑EDTA, lithium or sodium heparin, and sodium citrate) in adult patients with symptoms of hepatitis or at risk for hepatitis B virus (HBV) infection. The assay results, in conjunction with other serological and clinical information, may be used for the laboratory diagnosis of individuals with acute or chronic hepatitis B or recovery from hepatitis B infection.The electrochemiluminescence immunoassay “ECLIA” is intended for use oncobas e 602 immunoassay analyzers. en